Quadrant Capital Group LLC Sangamo Therapeutics, Inc Transaction History

Quadrant Capital Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$1.66 - $3.67 $854 - $1,890	515 Added 4.04%	13,249 $23,000
Q4 2022 Feb 10, 2023	BUY	$2.77 - $5.07 $31,555 - $57,757	11,392 Added 848.88%	12,734 $39,000
Q3 2022 Nov 10, 2022	SELL	$4.27 - $6.39 $10,888 - $16,294	-2,550 Reduced 65.52%	1,342 $7,000
Q2 2022 Aug 09, 2022	BUY	$3.28 - $6.21 $12,231 - $23,157	3,729 Added 2287.73%	3,892 $16,000
Q1 2022 May 06, 2022	BUY	$5.23 - $7.82 $852 - $1,274	163 New	163 $1,000
Q2 2020 Aug 13, 2020	SELL	$6.21 - $11.83 $552 - $1,052	-89 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $151 - $265	30 Added 50.85%	89 $0
Q2 2018 Aug 09, 2018	SELL	$13.9 - $19.8 $6,324 - $9,009	-455 Reduced 88.52%	59 $0
Q2 2017 Aug 15, 2017	BUY	N/A	514	514 $4,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.